BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 29.50
0.00 (0.00%)
May 8, 2026, 12:09 PM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 755.55 million as of May 8, 2026. Its market cap has decreased by -13.49% in one year.
Market Cap
755.55M
Enterprise Value
700.63M
Revenue
262.66M
Ranking
n/a
PE Ratio
17.88
Stock Price
29.50
Market Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 755.55M, a decrease of -52.21%. That is a compound annual growth rate of -8.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 755.55M | -4.84% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.06B |
| Lukas Biomedical | 1.06B |
| Taiwan Advance Bio-Pharmaceutical | 945.00M |
| TCI GENE | 922.08M |
| NatureWise Biotech & Medicals | 893.05M |
| MegaPro Biomedical | 847.84M |
| Neith | 793.51M |
| SynCore Biotechnology Co.,Ltd | 719.11M |